Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

900 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency.
Ono S, Takeshita K, Kiridoshi Y, Kato M, Kamiya T, Hoshino A, Yanagimachi M, Arai K, Takeuchi I, Toita N, Imamura T, Sasahara Y, Sugita J, Hamamoto K, Takeuchi M, Saito S, Onuma M, Tsujimoto H, Yasui M, Taga T, Arakawa Y, Mitani Y, Yamamoto N, Imai K, Suda W, Hattori M, Ohara O, Morio T, Honda K, Kanegane H. Ono S, et al. Among authors: yasui m. J Allergy Clin Immunol Pract. 2021 Oct;9(10):3767-3780. doi: 10.1016/j.jaip.2021.05.045. Epub 2021 Jul 8. J Allergy Clin Immunol Pract. 2021. PMID: 34246792
High rates of ovarian function preservation after hematopoietic cell transplantation with melphalan-based reduced intensity conditioning for pediatric acute leukemia: an analysis from the Japan Association of Childhood Leukemia Study (JACLS).
Fujino H, Ishida H, Iguchi A, Onuma M, Kato K, Shimizu M, Yasui M, Fujisaki H, Hamamoto K, Washio K, Sakaguchi H, Miyashita E, Osugi Y, Nakagami-Yamaguchi E, Hayakawa A, Sato A, Takahashi Y, Horibe K. Fujino H, et al. Among authors: yasui m. Int J Hematol. 2019 May;109(5):578-583. doi: 10.1007/s12185-019-02627-9. Epub 2019 Mar 12. Int J Hematol. 2019. PMID: 30864117
HLA-haploidentical peripheral blood stem cell transplantation following reduced-intensity conditioning with very low-dose antithymocyte globulin for relapsed/refractory acute leukemia in pediatric patients: a single-institution retrospective analysis.
Higuchi K, Sawada A, Kondo O, Okada Y, Tsujimoto H, Ioi A, Mayumi A, Shimizu M, Sato M, Goto K, Inoue S, Yasui M, Inoue M. Higuchi K, et al. Among authors: yasui m. Int J Hematol. 2022 Mar;115(3):406-413. doi: 10.1007/s12185-021-03270-z. Epub 2022 Jan 14. Int J Hematol. 2022. PMID: 35028882
Nationwide survey of bisphosphonate therapy for children with reactivated Langerhans cell histiocytosis in Japan.
Morimoto A, Shioda Y, Imamura T, Kanegane H, Sato T, Kudo K, Nakagawa S, Nakadate H, Tauchi H, Hama A, Yasui M, Nagatoshi Y, Kinoshita A, Miyaji R, Anan T, Yabe M, Kamizono J; LCH Committee, Japanese Pediatric Leukemia/Lymphoma Study Group. Morimoto A, et al. Among authors: yasui m. Pediatr Blood Cancer. 2011 Jan;56(1):110-5. doi: 10.1002/pbc.22703. Pediatr Blood Cancer. 2011. PMID: 21108445
Umbilical cord blood as an alternative source of reduced-intensity hematopoietic stem cell transplantation for chronic Epstein-Barr virus-associated T or natural killer cell lymphoproliferative diseases.
Sawada A, Inoue M, Koyama-Sato M, Kondo O, Yamada K, Shimizu M, Isaka K, Kimoto T, Kikuchi H, Tokimasa S, Yasui M, Kawa K. Sawada A, et al. Among authors: yasui m. Biol Blood Marrow Transplant. 2014 Feb;20(2):214-21. doi: 10.1016/j.bbmt.2013.10.026. Epub 2013 Nov 2. Biol Blood Marrow Transplant. 2014. PMID: 24188918 Free article.
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for advanced pediatric malignancies.
Sawada A, Shimizu M, Isaka K, Higuchi K, Mayumi A, Yoshimoto Y, Kikuchi H, Kondo O, Koyama-Sato M, Yasui M, Kawa K, Inoue M. Sawada A, et al. Among authors: yasui m. Pediatr Hematol Oncol. 2014 Nov;31(8):754-64. doi: 10.3109/08880018.2014.961214. Epub 2014 Oct 17. Pediatr Hematol Oncol. 2014. PMID: 25325678 Clinical Trial.
Intensified and prolonged therapy comprising cytarabine, vincristine and prednisolone improves outcome in patients with multisystem Langerhans cell histiocytosis: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A, Shioda Y, Imamura T, Kudo K, Kawaguchi H, Sakashita K, Yasui M, Koga Y, Kobayashi R, Ishii E, Fujimoto J, Horibe K, Bessho F, Tsunematsu Y, Imashuku S. Morimoto A, et al. Among authors: yasui m. Int J Hematol. 2016 Jul;104(1):99-109. doi: 10.1007/s12185-016-1993-3. Epub 2016 Apr 4. Int J Hematol. 2016. PMID: 27040279
900 results